…recently acknowledged that it took about $1.5M and 6 months to treat each patient. It’s a great idea but it’s still got some way to go before it reaches the…
…antibodies that recruit innate immune cells near tumors and activate them to kill cancer cells. T cells are immune cells that have a strong potential for use in cancer immunotherapies,…
…of the first type of stem cells, totipotent cells, that possess the ability to be programmed into any cell type, including embryonic and placental cells. Second are the pluripotent cells,…
…that intend to treat AML, multiple myeloma, pancreatic, ovarian, and triple negative breast cancer. Last year, the biotech was awarded a patent for CISH knockout (KO) in NK cells, which…
…ligands that it recognizes are also expressed by the tumor microenvironment, which comprises the blood vessels that support the tumor and the cells that make sure the tumor can evade…
…the most exciting areas in aging research. At the core of this technology is the concept of reverting mature cells to a pluripotent state to reset their biological age. The…
…senescent cells from harming the tissue around them instead of killing them. Another strategy — out-licensed to the Swiss company Rejuversen — is to stop senescent cells hiding from the…
…Cell competition is achieved by healthy normal cells that surround mutant cancer cells through various mechanisms that trigger cell removal. In addition, epithelial cells – the type of cell that…
…hard to replicate and translate to human studies. The use of stem cells can tackle these problems. Instead of trying to source scarce adult cells, researchers could simply turn plentiful…
…relapse. This led to the discovery that CAR-NK cells that express the gene interleukin-15 (IL-15) can provide a prolonged anti-tumor response. “Our data suggest that successful treatment using CAR-NK cells…
…cells help stimulate the patient’s T cells to identify and attack cancer cells expressing those antigens.” Hartenbach said that, in principle, dendritic cell therapy can target almost any type of…
…In fact, this class of drugs is the first cell therapy to target a solid tumor. Unlike CAR-T, where cells are retrieved from the blood, TIL therapy takes T cell…